Name | N-alpha-acetylglycinamide |
Synonyms | ACETYLGLUTAMIDE N-ACETYLGLYCINAMIDE N-Acetylglycinamide N-ACETYL GLYCINEAMIDE N-Acetylglycine amide N~2~-acetylglycinamide N-(2-oxoethyl)acetamide Nalpha-Acetylglycinamide 2-(Acetylamino)acetamide N-alpha-acetylglycinamide N-ALPHA-ACETYLGLYCINAMIDE 2-Acetamidoacetamide~Ac-Gly-NH_2 Acetamide, N-(2-amino-2-oxoethyl)- |
CAS | 2620-63-5 |
EINECS | 220-058-2 |
InChI | InChI=1/C4H8N2O2/c1-3(7)6-4(8)2-5/h2,5H2,1H3,(H,6,7,8) |
Molecular Formula | C4H8N2O2 |
Molar Mass | 116.12 |
Density | 1.3565 (rough estimate) |
Melting Point | 140-143°C(lit.) |
Boling Point | 213.59°C (rough estimate) |
Flash Point | 112.2°C |
Vapor Presure | 0.0112mmHg at 25°C |
BRN | 1753982 |
pKa | 15.58±0.46(Predicted) |
Storage Condition | Sealed in dry,Room Temperature |
Refractive Index | 1.4487 (estimate) |
MDL | MFCD00008029 |
Use | Mainly used for the treatment of nervous system diseases |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S37/39 - Wear suitable gloves and eye/face protection |
WGK Germany | 3 |
RTECS | MB7507000 |
Reference Show more | 1. [IF=5.81] Yu Li et al."Pharmacokinetics of Active Components From Guhong Injection in Normal and Pathological Rat Models of Cerebral Ischemia: A Comparative Study."Front Pharmacol. 2018 May;0:493 |
use | master for neurological diseases. Mainly used for the treatment of nervous system diseases Used for nervous system diseases; used for the treatment of nervous system diseases |
production method | is made from glutamine. |